These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7752387)

  • 1. Histologic studies of intravesical oxybutynin in the rabbit.
    Landau EH; Fung LC; Thorner PS; Mittelman MW; Jayanthi VR; Churchill BM; McLorie GA; Steckler RE; Khoury AE
    J Urol; 1995 Jun; 153(6):2022-4. PubMed ID: 7752387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urodynamic effects of intravesical oxybutynin chloride in conscious rats.
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    J Urol; 1996 Feb; 155(2):768-71. PubMed ID: 8558722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization].
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia.
    Painter KA; Vates TS; Bukowski TP; Fleming P; Freedman AL; Smith CA; Gonzalez R; Perlmutter AD
    J Urol; 1996 Oct; 156(4):1459-62. PubMed ID: 8808907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Topical administration of oxybutynin hydrochloride in women with urge incontinence. Results of a prospective randomized double-blind study].
    Enzelsberger H; Kurz C; Helmer H; Mittermayer F
    Geburtshilfe Frauenheilkd; 1995 May; 55(5):240-3. PubMed ID: 7607378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The durability of intravesical oxybutynin solutions over time.
    Wan J; Rickman C
    J Urol; 2007 Oct; 178(4 Pt 2):1768-70. PubMed ID: 17707431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical effect of intravesical oxybutynin.
    Bonney WW; Robinson RA; Theobald RJ
    J Urol; 1993 Nov; 150(5 Pt 1):1522-5. PubMed ID: 8411446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathologic and Urodynamic Effects of the Anticholinergic Drugs Oxybutynin, Tolterodine, and Trospium on the Bladder.
    Orgen S; Deliktas H; Sahin H; Gedik A; Nergis Y
    Low Urin Tract Symptoms; 2017 Jan; 9(1):52-56. PubMed ID: 28120444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical oxybutynin chloride and clean intermittent catheterisation in patients with neurogenic vesical dysfunction and decreased bladder capacity.
    Prasad KV; Vaidyanathan S
    Br J Urol; 1993 Nov; 72(5 Pt 2):719-22. PubMed ID: 8281402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of oxybutynin in children with detrusor hyperreflexia secondary to neurogenic bladder dysfunction.
    Franco I; Horowitz M; Grady R; Adams RC; de Jong TP; Lindert K; Albrecht D
    J Urol; 2005 Jan; 173(1):221-5. PubMed ID: 15592080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical electromotive administration of oxybutynin in patients with detrusor hyperreflexia unresponsive to standard anticholinergic regimens.
    Di Stasi SM; Giannantoni A; Vespasiani G; Navarra P; Capelli G; Massoud R; Stephen RL
    J Urol; 2001 Feb; 165(2):491-8. PubMed ID: 11176403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Value of intravesically instilled oxybutynin in refractory bladder hyperactivity. Study of 15 cases].
    Amarenco G; Adba MA; Kerdraon J
    Prog Urol; 1992; 2(4):660-3. PubMed ID: 1302108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravesical oxybutynin: a local anesthetic effect on bladder C afferents.
    De Wachter S; Wyndaele JJ
    J Urol; 2003 May; 169(5):1892-5. PubMed ID: 12686868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intravesical oxybutynin in children with meningomyelocele. Efficient treatment with few side-effects].
    Von Zweigbergk M; Nordin B; Jonsson S
    Lakartidningen; 1996 Oct; 93(41):3573-6. PubMed ID: 8965514
    [No Abstract]   [Full Text] [Related]  

  • 15. [Intravesical instillation of trospium chloride, oxybutynin and verapamil for relaxation of the bladder detrusor muscle. A placebo controlled, randomized clinical test].
    Fröhlich G; Burmeister S; Wiedemann A; Bulitta M
    Arzneimittelforschung; 1998 May; 48(5):486-91. PubMed ID: 9638316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of neurogenic bladder dysfunction in infants and children with neurospinal dysraphism with clean intermittent (self)catheterisation and optimized intravesical oxybutynin hydrochloride therapy.
    Buyse G; Verpoorten C; Vereecken R; Casaer P
    Eur J Pediatr Surg; 1995 Dec; 5 Suppl 1():31-4. PubMed ID: 8770576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with modified intravesical oxybutynin chloride for neurogenic bladder in children.
    Hayashi A; Saito M; Okada S; Hanada T; Watanabe T; Satoh K; Kanzaki S
    J Pediatr Urol; 2007 Dec; 3(6):438-42. PubMed ID: 18947791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of percutaneous and intraduodenal administration of oxybutynin on bladder contraction and salivation in rabbits.
    Kontani H; Hamamoto T; Takeuchi S; Nomura Y; Sawanishi H; Saito H
    Int J Urol; 2006 Jul; 13(7):977-84. PubMed ID: 16882066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial.
    Fader M; Glickman S; Haggar V; Barton R; Brooks R; Malone-Lee J
    J Urol; 2007 Jan; 177(1):208-13; discussion 213. PubMed ID: 17162046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population.
    Palmer LS; Zebold K; Firlit CF; Kaplan WE
    J Urol; 1997 Feb; 157(2):638-40. PubMed ID: 8996387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.